February 13, 2023
None
National Institute on Drug Abuse (NIDA)
The purpose of this notice announces the participation of the National Institute on Drug Abuse (NIDA), effective immediately, in a joint initiative, the Incorporating Human Behavior in Epidemiological Models (IHBEM) Program, in collaboration with the National Science Foundation (NSF).
The IHBEM announcement is released under NSF-23-546. The purpose of the IHBEM activity is to support interdisciplinary collaborations that integrate research on behavioral and/or social processes in mathematical epidemiological models. Projects supported under this activity should be collaborative in nature and have coordinated interaction of two or more PIs/co-PIs, with balanced participation from the mathematical sciences and the social, behavioral, or economic sciences. Additional participants from other disciplines, especially the biological sciences, are also welcome.
NIDA is specifically interested in applications that support scientific research on drug use and its health and social consequences across the spectrum, from occasional use to problematic use and substance use disorders (SUDs). Some examples of areas of interest include:
NIH/NIDA Additional Eligibility Information
Application Preparation and Submission Instructions
Proposals submitted in response to this program solicitation should be prepared and submitted in accordance with the general guidelines contained in the NSF Proposal & Award Policies & Procedures Guide (PAPPG). The complete text of the PAPPG is available electronically on the NSF website at: https://www.nsf.gov/publications/pub_summ.jsp?ods_key=pappg. Paper copies of the PAPPG may be obtained from the NSF Publications Clearinghouse, telephone (703) 292-8134 or by e-mail [email protected]. Proposers are reminded to identify this program solicitation number in the program solicitation block on the NSF Cover Sheet for Proposal to the National Science Foundation. Compliance with this requirement is critical to determining the relevant proposal processing guidelines. Failure to submit this information may delay processing.
Budgetary Information
Under this solicitation, proposals may be submitted for up to the duration of four years and with budgets totaling no more than $1,000,000. The budget must be commensurate with the project and thoroughly justified in the proposal. The IHBEM Program expects to fund approximately 10-15 awards per year, depending on the quality of submissions and the availability of funds.
Inclusion of voluntary committed cost sharing is prohibited.
NIH Process
Proposals selected for funding consideration by NIH will be invited to submit reformatted applications to the Division of Receipt and Referral (DRR) in NIH's Center for Scientific Review (CSR). Following the initial peer review, recommended applications that have been resubmitted to the NIH are required to go to second level review by the Advisory Council or Advisory Board of the awarding Institute or Center. PD/PIs invited to submit to NIH will receive further information on submission procedures from NIH. An applicant will not be allowed to increase the proposed budget or change the scientific content of the proposal in the submission to the NIH. For information purposes, NIH PD/PIs may wish to consult the OER website which provides excellent general information about all aspects of NIH grantsmanship, including competitive renewals (https://grants.nih.gov/grants/grants_process.htm).
The following will be considered in making funding decisions:
Subsequent award processing and grant administration procedures will be in accordance with NIH policies and procedures.
Information about all aspects of NIH grantsmanship, including competitive renewals (https://grants.nih.gov/grants/grants_process.htm).
Inquiries are encouraged and NIH Scientific/Research contacts are listed below. Please see the NSF IHBEM website for names and contact information of participating NSF Directorates.
Susan N. Wright, PhD
National Institute on Drug Abuse (NIDA), Division of Neuroscience and Behavior (DNB)
Telephone: (301) 402-6683
Email: [email protected]
Janet Kuramoto-Crawford, PhD
National Institute on Drug Abuse (NIDA), Division of Epidemiology, Services and Prevention Research (DESPR)
Telephone: (301) 443-8856
Email: [email protected]